CTOs on the Move


 
Kronus is a Boise, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.kronus.com
  • 12554 W Bridger St Ste 108
    Boise, ID USA 83713
  • Phone: 208.377.4800

Executives

Name Title Contact Details

Similar Companies

Michiana Behavioral Health Center

Michiana Behavioral Health Center is a Plymouth, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Humco Holding Group

Humco Holding Group, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Humco Holding Group, Inc. is based in Texarkana, TX. You can find more information on Humco Holding Group, Inc. at www.humco.com

Delaware Hospice

Delaware Hospice is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Wilmington, DE. To find more information about Delaware Hospice, please visit www.delawarehospice.org

Allergen Research

Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.

Fitness Connection United States

At Fitness Connection, we exist to change lives every day. We are in the business because we truly believe that what we do can make the world a better place. That is why we chose to make a healthier lifestyle more accessible by providing a high-quality experience at a value.